-

PerkinElmer to Host Virtual Investor and Analyst Day

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will host a virtual Investor and Analyst Day on Thursday, June 24, 2021 from 8:30 a.m. to 12:00 p.m. ET.

The virtual format will feature presentations by members of PerkinElmer’s senior management team including an update on business conditions and the meeting will conclude with a Q&A session.

A live webcast will be available to registered attendees on the Investors section of the Company’s website at www.perkinelmer.com. We encourage interested parties to preregister prior to the start of the event. A replay of the webcast will be available on the PerkinElmer website following the presentation.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $3.8 billion in 2020, has more than 14,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Contacts

Investor Relations:
Bryan Kipp
(781) 663-5583
bryan.kipp@perkinelmer.com

Media Relations:
Chet Murray
(781) 663-5719
Chet.Murray@perkinelmer.com

Industry:

PerkinElmer, Inc.

NYSE:PKI
Release Versions
English

Contacts

Investor Relations:
Bryan Kipp
(781) 663-5583
bryan.kipp@perkinelmer.com

Media Relations:
Chet Murray
(781) 663-5719
Chet.Murray@perkinelmer.com

More News From PerkinElmer, Inc.

PerkinElmer Launches Cloud Based Solution to Enable Remote Lab Management

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its PKeye™ Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows in real-time. The PKeye Workflow Monitor offers scientists and researchers 24/7 access and visibility into their laboratory operations. With a cloud-based web design and centralized summary dashboa...

PerkinElmer Releases 2021 Corporate Social Responsibility Report

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader innovating for a healthier world, today released its 2021 Corporate Social Responsibility (CSR) Report, which summarizes the latest achievements of its environmental, social and governance (ESG) program. The report titled, “Strengthening Our Commitments for Sustainable Impact,” also outlines four new ESG commitments unveiled by the Company earlier this year and describes its reporting framework established in accord...

PerkinElmer Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel 1 assay. Qualified laboratories can immediately begin using this single test for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) isolated from nasopharyngeal swabs, anterior nasal swabs...
Back to Newsroom